Connecting Research and Experts with Journalists

• share
• favorite_border

A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering similar benefits to patients with difficult-to-treat meningioma, a type of brain tumor. Findings of the nonrandomized phase II study will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

• share
• favorite_border

In addition to the studies featured on the press program (details here) for the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting, the following studies were recommended by ASTRO experts and may be of interest to journalists.

• share
• favorite_border

This special edition features advances in radiation therapy approaches presented by MD Anderson researchers at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting. Information on all MD Anderson ASTRO Annual Meeting content can be found at MDAnderson.org/ASTRO.

• share
• favorite_border

The annual meeting will feature 23 abstracts from UCLA investigators that highlight key areas of radiation oncology, including new research in subspecialties ranging from survivorship, lung cancer/thoracic malignancies, physics, sarcoma, gastrointestinal cancer, genitourinary cancer, gynecological cancer, pediatric cancer and diversity, equity and inclusion in healthcare.

• share
• favorite_border

Leading experts in radiation therapy from Penn Medicine’s Abramson Cancer Center and the Perelman School of Medicine will present new results from clinical trials and research studies at the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting.

• share
• favorite_border

Irvine, Calif., Sept. 27, 2024 — Research from the University of California, Irvine has revealed how disruption of the circadian clock, the body’s internal, 24-hour biological pacemaker, may accelerate the progression of colorectal cancer by affecting the gut microbiome and intestinal barrier function. This discovery offers new avenues for prevention and treatment strategies.

• share
• favorite_border

A new, integrated system will enable ocean science, exploration, and restoration efforts from a wider range of vessels, paving the way for more successful and efficient operations

• share
• favorite_border

Researchers looking for materials that conduct electrons with near-zero resistance at normal operating temperature have found a promising candidate. The material, a layered "sandwich" of bismuth telluride and manganese bismuth telluride structure, exhibits the quantum anomalous Hall effect. In this effect, electrons with their spins all aligned in the same direction can travel along the edges of a material with almost no resistance.

• share
• favorite_border

Researchers at Fred Hutch Cancer Center identified a substantial increase over the past decade in the proportion of patients with cancer in the U.S. who participate in pharmaceutical industry sponsored clinical trials compared to those conducted with federal government support. Published in The Journal of Clinical Oncology and presented at the ASCO Quality Care Symposium, these findings reveal trends of underinvestment in federally funded studies, flat enrollment counts in federally funded studies over more than a decade and a growing reliance on industry to conduct cancer research.

• share
• favorite_border

Researchers with McMaster University have made an important Huntington’s Disease discovery. Members of the Truant Lab have found that the protein mutated in patients with Huntington’s Disease doesn't repair DNA as intended, impacting the ability of brain cells to heal themselves.